Discovery of Potent and Orally Bioavailable Dihydropyrazole GPR40 Agonists. 2018

Jun Shi, and Zhengxiang Gu, and Elizabeth Anne Jurica, and Ximao Wu, and Lauren E Haque, and Kristin N Williams, and Andres S Hernandez, and Zhenqiu Hong, and Qi Gao, and Marta Dabros, and Akin H Davulcu, and Arvind Mathur, and Richard A Rampulla, and Arun Kumar Gupta, and Ramya Jayaram, and Atsu Apedo, and Douglas B Moore, and Heng Liu, and Lori K Kunselman, and Edward J Brady, and Jason J Wilkes, and Bradley A Zinker, and Hong Cai, and Yue-Zhong Shu, and Qin Sun, and Elizabeth A Dierks, and Kimberly A Foster, and Carrie Xu, and Tao Wang, and Reshma Panemangalore, and Mary Ellen Cvijic, and Chunshan Xie, and Gary G Cao, and Min Zhou, and John Krupinski, and Jean M Whaley, and Jeffrey A Robl, and William R Ewing, and Bruce Alan Ellsworth
Research and Development, Bristol-Myers Squibb Co. , P.O. Box 4000, Princeton, New Jersey 08540-4000, United States.

G protein-coupled receptor 40 (GPR40) has become an attractive target for the treatment of diabetes since it was shown clinically to promote glucose-stimulated insulin secretion. Herein, we report our efforts to develop highly selective and potent GPR40 agonists with a dual mechanism of action, promoting both glucose-dependent insulin and incretin secretion. Employing strategies to increase polarity and the ratio of sp3/sp2 character of the chemotype, we identified BMS-986118 (compound 4), which showed potent and selective GPR40 agonist activity in vitro. In vivo, compound 4 demonstrated insulinotropic efficacy and GLP-1 secretory effects resulting in improved glucose control in acute animal models.

UI MeSH Term Description Entries
D008297 Male Males
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D008968 Molecular Conformation The characteristic three-dimensional shape of a molecule. Molecular Configuration,3D Molecular Structure,Configuration, Molecular,Molecular Structure, Three Dimensional,Three Dimensional Molecular Structure,3D Molecular Structures,Configurations, Molecular,Conformation, Molecular,Conformations, Molecular,Molecular Configurations,Molecular Conformations,Molecular Structure, 3D,Molecular Structures, 3D,Structure, 3D Molecular,Structures, 3D Molecular
D011720 Pyrazoles Azoles of two nitrogens at the 1,2 positions, next to each other, in contrast with IMIDAZOLES in which they are at the 1,3 positions.
D011759 Pyrrolidines Compounds also known as tetrahydropyridines with general molecular formula (CH2)4NH. Tetrahydropyridine,Tetrahydropyridines
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities
D043562 Receptors, G-Protein-Coupled The largest family of cell surface receptors involved in SIGNAL TRANSDUCTION. They share a common structure and signal through HETEROTRIMERIC G-PROTEINS. G Protein Coupled Receptor,G-Protein-Coupled Receptor,G-Protein-Coupled Receptors,G Protein Coupled Receptors,Receptor, G-Protein-Coupled,Receptors, G Protein Coupled

Related Publications

Jun Shi, and Zhengxiang Gu, and Elizabeth Anne Jurica, and Ximao Wu, and Lauren E Haque, and Kristin N Williams, and Andres S Hernandez, and Zhenqiu Hong, and Qi Gao, and Marta Dabros, and Akin H Davulcu, and Arvind Mathur, and Richard A Rampulla, and Arun Kumar Gupta, and Ramya Jayaram, and Atsu Apedo, and Douglas B Moore, and Heng Liu, and Lori K Kunselman, and Edward J Brady, and Jason J Wilkes, and Bradley A Zinker, and Hong Cai, and Yue-Zhong Shu, and Qin Sun, and Elizabeth A Dierks, and Kimberly A Foster, and Carrie Xu, and Tao Wang, and Reshma Panemangalore, and Mary Ellen Cvijic, and Chunshan Xie, and Gary G Cao, and Min Zhou, and John Krupinski, and Jean M Whaley, and Jeffrey A Robl, and William R Ewing, and Bruce Alan Ellsworth
May 2013, Bioorganic & medicinal chemistry letters,
Jun Shi, and Zhengxiang Gu, and Elizabeth Anne Jurica, and Ximao Wu, and Lauren E Haque, and Kristin N Williams, and Andres S Hernandez, and Zhenqiu Hong, and Qi Gao, and Marta Dabros, and Akin H Davulcu, and Arvind Mathur, and Richard A Rampulla, and Arun Kumar Gupta, and Ramya Jayaram, and Atsu Apedo, and Douglas B Moore, and Heng Liu, and Lori K Kunselman, and Edward J Brady, and Jason J Wilkes, and Bradley A Zinker, and Hong Cai, and Yue-Zhong Shu, and Qin Sun, and Elizabeth A Dierks, and Kimberly A Foster, and Carrie Xu, and Tao Wang, and Reshma Panemangalore, and Mary Ellen Cvijic, and Chunshan Xie, and Gary G Cao, and Min Zhou, and John Krupinski, and Jean M Whaley, and Jeffrey A Robl, and William R Ewing, and Bruce Alan Ellsworth
April 2017, Journal of medicinal chemistry,
Jun Shi, and Zhengxiang Gu, and Elizabeth Anne Jurica, and Ximao Wu, and Lauren E Haque, and Kristin N Williams, and Andres S Hernandez, and Zhenqiu Hong, and Qi Gao, and Marta Dabros, and Akin H Davulcu, and Arvind Mathur, and Richard A Rampulla, and Arun Kumar Gupta, and Ramya Jayaram, and Atsu Apedo, and Douglas B Moore, and Heng Liu, and Lori K Kunselman, and Edward J Brady, and Jason J Wilkes, and Bradley A Zinker, and Hong Cai, and Yue-Zhong Shu, and Qin Sun, and Elizabeth A Dierks, and Kimberly A Foster, and Carrie Xu, and Tao Wang, and Reshma Panemangalore, and Mary Ellen Cvijic, and Chunshan Xie, and Gary G Cao, and Min Zhou, and John Krupinski, and Jean M Whaley, and Jeffrey A Robl, and William R Ewing, and Bruce Alan Ellsworth
March 2015, ACS medicinal chemistry letters,
Jun Shi, and Zhengxiang Gu, and Elizabeth Anne Jurica, and Ximao Wu, and Lauren E Haque, and Kristin N Williams, and Andres S Hernandez, and Zhenqiu Hong, and Qi Gao, and Marta Dabros, and Akin H Davulcu, and Arvind Mathur, and Richard A Rampulla, and Arun Kumar Gupta, and Ramya Jayaram, and Atsu Apedo, and Douglas B Moore, and Heng Liu, and Lori K Kunselman, and Edward J Brady, and Jason J Wilkes, and Bradley A Zinker, and Hong Cai, and Yue-Zhong Shu, and Qin Sun, and Elizabeth A Dierks, and Kimberly A Foster, and Carrie Xu, and Tao Wang, and Reshma Panemangalore, and Mary Ellen Cvijic, and Chunshan Xie, and Gary G Cao, and Min Zhou, and John Krupinski, and Jean M Whaley, and Jeffrey A Robl, and William R Ewing, and Bruce Alan Ellsworth
September 2010, ACS medicinal chemistry letters,
Jun Shi, and Zhengxiang Gu, and Elizabeth Anne Jurica, and Ximao Wu, and Lauren E Haque, and Kristin N Williams, and Andres S Hernandez, and Zhenqiu Hong, and Qi Gao, and Marta Dabros, and Akin H Davulcu, and Arvind Mathur, and Richard A Rampulla, and Arun Kumar Gupta, and Ramya Jayaram, and Atsu Apedo, and Douglas B Moore, and Heng Liu, and Lori K Kunselman, and Edward J Brady, and Jason J Wilkes, and Bradley A Zinker, and Hong Cai, and Yue-Zhong Shu, and Qin Sun, and Elizabeth A Dierks, and Kimberly A Foster, and Carrie Xu, and Tao Wang, and Reshma Panemangalore, and Mary Ellen Cvijic, and Chunshan Xie, and Gary G Cao, and Min Zhou, and John Krupinski, and Jean M Whaley, and Jeffrey A Robl, and William R Ewing, and Bruce Alan Ellsworth
September 2012, ACS medicinal chemistry letters,
Jun Shi, and Zhengxiang Gu, and Elizabeth Anne Jurica, and Ximao Wu, and Lauren E Haque, and Kristin N Williams, and Andres S Hernandez, and Zhenqiu Hong, and Qi Gao, and Marta Dabros, and Akin H Davulcu, and Arvind Mathur, and Richard A Rampulla, and Arun Kumar Gupta, and Ramya Jayaram, and Atsu Apedo, and Douglas B Moore, and Heng Liu, and Lori K Kunselman, and Edward J Brady, and Jason J Wilkes, and Bradley A Zinker, and Hong Cai, and Yue-Zhong Shu, and Qin Sun, and Elizabeth A Dierks, and Kimberly A Foster, and Carrie Xu, and Tao Wang, and Reshma Panemangalore, and Mary Ellen Cvijic, and Chunshan Xie, and Gary G Cao, and Min Zhou, and John Krupinski, and Jean M Whaley, and Jeffrey A Robl, and William R Ewing, and Bruce Alan Ellsworth
January 2012, Bioorganic & medicinal chemistry letters,
Jun Shi, and Zhengxiang Gu, and Elizabeth Anne Jurica, and Ximao Wu, and Lauren E Haque, and Kristin N Williams, and Andres S Hernandez, and Zhenqiu Hong, and Qi Gao, and Marta Dabros, and Akin H Davulcu, and Arvind Mathur, and Richard A Rampulla, and Arun Kumar Gupta, and Ramya Jayaram, and Atsu Apedo, and Douglas B Moore, and Heng Liu, and Lori K Kunselman, and Edward J Brady, and Jason J Wilkes, and Bradley A Zinker, and Hong Cai, and Yue-Zhong Shu, and Qin Sun, and Elizabeth A Dierks, and Kimberly A Foster, and Carrie Xu, and Tao Wang, and Reshma Panemangalore, and Mary Ellen Cvijic, and Chunshan Xie, and Gary G Cao, and Min Zhou, and John Krupinski, and Jean M Whaley, and Jeffrey A Robl, and William R Ewing, and Bruce Alan Ellsworth
March 2011, Bioorganic & medicinal chemistry letters,
Jun Shi, and Zhengxiang Gu, and Elizabeth Anne Jurica, and Ximao Wu, and Lauren E Haque, and Kristin N Williams, and Andres S Hernandez, and Zhenqiu Hong, and Qi Gao, and Marta Dabros, and Akin H Davulcu, and Arvind Mathur, and Richard A Rampulla, and Arun Kumar Gupta, and Ramya Jayaram, and Atsu Apedo, and Douglas B Moore, and Heng Liu, and Lori K Kunselman, and Edward J Brady, and Jason J Wilkes, and Bradley A Zinker, and Hong Cai, and Yue-Zhong Shu, and Qin Sun, and Elizabeth A Dierks, and Kimberly A Foster, and Carrie Xu, and Tao Wang, and Reshma Panemangalore, and Mary Ellen Cvijic, and Chunshan Xie, and Gary G Cao, and Min Zhou, and John Krupinski, and Jean M Whaley, and Jeffrey A Robl, and William R Ewing, and Bruce Alan Ellsworth
July 2018, ACS medicinal chemistry letters,
Jun Shi, and Zhengxiang Gu, and Elizabeth Anne Jurica, and Ximao Wu, and Lauren E Haque, and Kristin N Williams, and Andres S Hernandez, and Zhenqiu Hong, and Qi Gao, and Marta Dabros, and Akin H Davulcu, and Arvind Mathur, and Richard A Rampulla, and Arun Kumar Gupta, and Ramya Jayaram, and Atsu Apedo, and Douglas B Moore, and Heng Liu, and Lori K Kunselman, and Edward J Brady, and Jason J Wilkes, and Bradley A Zinker, and Hong Cai, and Yue-Zhong Shu, and Qin Sun, and Elizabeth A Dierks, and Kimberly A Foster, and Carrie Xu, and Tao Wang, and Reshma Panemangalore, and Mary Ellen Cvijic, and Chunshan Xie, and Gary G Cao, and Min Zhou, and John Krupinski, and Jean M Whaley, and Jeffrey A Robl, and William R Ewing, and Bruce Alan Ellsworth
January 2024, Journal of medicinal chemistry,
Jun Shi, and Zhengxiang Gu, and Elizabeth Anne Jurica, and Ximao Wu, and Lauren E Haque, and Kristin N Williams, and Andres S Hernandez, and Zhenqiu Hong, and Qi Gao, and Marta Dabros, and Akin H Davulcu, and Arvind Mathur, and Richard A Rampulla, and Arun Kumar Gupta, and Ramya Jayaram, and Atsu Apedo, and Douglas B Moore, and Heng Liu, and Lori K Kunselman, and Edward J Brady, and Jason J Wilkes, and Bradley A Zinker, and Hong Cai, and Yue-Zhong Shu, and Qin Sun, and Elizabeth A Dierks, and Kimberly A Foster, and Carrie Xu, and Tao Wang, and Reshma Panemangalore, and Mary Ellen Cvijic, and Chunshan Xie, and Gary G Cao, and Min Zhou, and John Krupinski, and Jean M Whaley, and Jeffrey A Robl, and William R Ewing, and Bruce Alan Ellsworth
April 2020, ACS medicinal chemistry letters,
Copied contents to your clipboard!